Clinical Trials Directory

Trials / Unknown

UnknownNCT05084469

Exploration of Cluster Headache in a PET-MRI Study

Exploration of the 5-HT1A Receptor in Cluster Headache : a PET-MRI Study Using the PET Radiopharmaceutical [18F]F13640

Status
Unknown
Phase
Study type
Observational
Enrollment
12 (estimated)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
Male
Age
20 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Observational study in PET-MRI using the 5-HT1A agonist PET radiotracer \[18F\]F13640.

Conditions

Interventions

TypeNameDescription
PROCEDUREPET-MRI in pain-free remission periodPatients will performed PET-MRI scans. A first 30 minutes acquisition will be performed at time=60min after injection. A second 75 minutes acquisition will be performed at time=150min. Each scans will contain functional dynamic \[18F\]F13640 PET acquisition, anatomical and functional MRI images acquisition and pain evaluation using a score visual analogic scale.

Timeline

Start date
2021-11-01
Primary completion
2024-02-01
Completion
2024-02-01
First posted
2021-10-19
Last updated
2021-10-19

Source: ClinicalTrials.gov record NCT05084469. Inclusion in this directory is not an endorsement.

Exploration of Cluster Headache in a PET-MRI Study (NCT05084469) · Clinical Trials Directory